Why the study?
Does N-acetylcysteine prevent the deleterious effects of TNF-alpha on calcium transients and contraction in adult rat cardiomyocytes?
Does N-acetylcysteine prevent the deleterious effects of TNF-alpha on calcium transients and contraction in adult rat cardiomyocytes?
Glutathione supplementation with N-acetylcysteine prevents the adverse contractile effects of TNF-alpha in rat cardiomyocytes, suggesting a potential therapeutic mechanism for heart failure.
Answers are grounded in this paper and cite their sources.
NAC may blunt TNF-alpha effects on rat cardiomyocyte function; hypothesis-generating for heart failure therapy with no human data yet.
BACKGROUND: The negative effect of tumor necrosis factor-alpha (TNF-alpha) on heart contraction, which is mediated by sphingosine, is a major component in heart failure. Because the cellular level of glutathione may limit sphingosine production via the inhibition of the Mg-dependent neutral sphingomyelinase (N-SMase), we hypothesized that cardiac glutathione status might determine the negative contractile response to TNF-alpha. METHODS AND RESULTS: We examined the effects of TNF-alpha in isolated cardiomyocytes obtained from control rats or rats that were given the glutathione precursor N-acetylcysteine (NAC, 100 mg IP per animal). In cardiomyocytes obtained from control rats, 25 ng/mL TNF-alpha increased reactive oxygen species generation and N-SMase activity (500% and 34% over basal, respectively) and decreased the amplitude of [Ca(2+)](i) in response to electrical stimulation (22% below basal). NAC treatment increased cardiac glutathione content by 42%. In cardiomyocytes obtained from NAC-treated rats, 25 ng/mL TNF-alpha had no effect on reactive oxygen species production or N-SMase activity but increased the amplitude of [Ca(2+)](i) transients and contraction in response to electrical stimulation by 40% to 50% over basal after 20 minutes. This was associated with a hastened relaxation (20% reduction in t(1/2) compared with basal) and an increased phosphorylation of both Ser(16)- and Thr(17)-phospholamban residues (260% and 115% of maximal isoproterenol effect, respectively). CONCLUSIONS: It is concluded that cardiac glutathione status, by controlling N-SMase activation, determines the severity of the adverse effects of TNF-alpha on heart contraction. Glutathione supplementation may therefore provide therapeutic benefits for vulnerable hearts.
No takes yet. Share an insight, caveat, or question.
Cailleret et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: